Back
Trevi Therapeutics Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
TRVI
Trevi Therapeutics
Last Price:
$3.99
Seasonality Move:
52.76%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Trevi Therapeutics Stock Forecast
-
Is Trevi Therapeutics Stock Undervalued?The current Trevi Therapeutics [TRVI] share price is $4.00. The Score for TRVI is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
TRVI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Trevi Therapeutics Stock Go Up Next Year?
Data Unavailable
Trevi Therapeutics Stock Rating
Data Unavailable
Trevi Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
trevitherapeutics.com
52-Week Data
52-Week High:
4.68
52-Week Low:
1.27
Prediction Charts
Market Cap:
307.5M
Price in USD:
4.00
Volume:
441.5K
Beta:
0.85
Technical Analysis
SMA50:
3.15
SMA100:
3.09
SMA200:
2.98
52-Wk Change:
187.77%
Stock Predictions
-
Is Trevi Therapeutics stock public?Yes, Trevi Therapeutics is a publicly traded company.
-
What is the Trevi Therapeutics stock quote today?The Trevi Therapeutics stock price is 4.00 USD today.
-
How to buy Trevi Therapeutics stock online?You can buy Trevi Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-5 | 2.61 | 2.60 | 2.63 | 2.49 |
| Dec-6 | 2.63 | 2.76 | 2.80 | 2.56 |
| Dec-9 | 2.76 | 2.66 | 2.86 | 2.57 |
| Dec-10 | 2.68 | 2.68 | 2.78 | 2.66 |
| Dec-11 | 2.73 | 2.49 | 2.73 | 2.36 |
| Dec-12 | 3.91 | 3.60 | 4.60 | 3.43 |
| Dec-13 | 3.95 | 4.17 | 4.28 | 3.75 |
| Dec-16 | 4.30 | 4.24 | 4.52 | 4.01 |
| Dec-17 | 4.39 | 4.50 | 4.60 | 4.17 |
| Dec-18 | 4.57 | 4.16 | 4.68 | 4.08 |
| Dec-19 | 4.24 | 4.15 | 4.42 | 4.12 |
| Dec-20 | 4.06 | 4.05 | 4.39 | 4.05 |
| Dec-23 | 4.01 | 4.06 | 4.16 | 3.88 |
| Dec-24 | 4.05 | 4.00 | 4.15 | 3.96 |
Trevi Therapeutics Earnings
Data Unavailable
Trevi Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and an increase next year of $0.00 per share.
* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.